risarestat has been researched along with Alloxan Diabetes in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, HM; Kajiwara, K; Ono, M; Toda, T; Tsubota, K; Yoshida, M | 1 |
Awata, T; Hosotani, H; Kinoshita, S; Matsumoto, T; Ohashi, Y | 1 |
Glover, JP; Hosotani, H; Jacot, JL; Lois, N; Robison, WG | 1 |
3 other study(ies) available for risarestat and Alloxan Diabetes
Article | Year |
---|---|
Aldose reductase inhibition and the phosphorus-31 profile of the intact diabetic rat lens.
Topics: Adenosine Triphosphate; Administration, Oral; Administration, Topical; Aldehyde Reductase; Animals; Carbohydrate Metabolism; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Female; Lens, Crystalline; Magnetic Resonance Spectroscopy; Phosphates; Phosphorus Isotopes; Rats; Rats, Wistar; Streptozocin; Thiazoles; Thiazolidinediones | 1993 |
Effects of topical aldose reductase inhibitor CT-112 on corneal sensitivity of diabetic rats.
Topics: Administration, Topical; Aldehyde Reductase; Animals; Blinking; Cornea; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Hypesthesia; Male; Ophthalmic Solutions; Rats; Rats, Sprague-Dawley; Thiazoles; Thiazolidinediones; Trigeminal Nerve | 1996 |
Diabetic-like corneal sensitivity loss in galactose-fed rats ameliorated with aldose reductase inhibitors.
Topics: Aldehyde Reductase; Animals; Blinking; Cataract; Cornea; Diabetes Mellitus, Experimental; Diet; Enzyme Inhibitors; Fluorenes; Galactose; Galactosemias; Hydantoins; Male; Physical Stimulation; Rats; Rats, Sprague-Dawley; Thiazoles; Thiazolidinediones | 1998 |